Surgimab
  • Science
    • Technology
    • Pipeline
    • Clinical trials
    • Publications
  • About SurgiMab
    • History
    • Our team
    • Partners
  • News
  • Contact
Select Page
SurgiMab launches clinical trial in patients with pancreatic or rectal cancer

SurgiMab launches clinical trial in patients with pancreatic or rectal cancer

by kwal1 | Feb 5, 2016 | News

Montpellier, France, February 5th, 2016. SurgiMab announces the launch of a phase I clinical trial program evaluating the safety and performance of its fluorescent conjugate SGM-101 in patients with pancreatic or rectal cancer. SurgiMab, founded in 2011 in...

Hawaï. SurgiMab is happy to be a sponsor for the one-day Optical Surgical Navigation Seminar organised during WMIC.

by kwal1 | Sep 2, 2015 | News

SurgiMab is happy to be part of the sponsors for the one-day Optical Surgical Navigation Seminar that is organized on september the 2nd during the World Molecular Imaging Congress in Hawaï. SurgiMab will also present its latest results on September 3rd during the WMIC...

First-in-human phase I study for SurgiMab’s molecule SGM-101 launched in Montpellier Cancer Institute

by kwal1 | May 15, 2015 | News

SurgiMab, a French company founded in 2011 in Montpellier, is developing antibody-fluorochrome conjugates as in vivo diagnostic agents in oncology. “Today we are pleased to announce that Montpellier Cancer Institute (ICM) has started patient inclusion in a phase I...
SurgiMab is part of the 15 laureates of the 2014 Netva competition

SurgiMab is part of the 15 laureates of the 2014 Netva competition

by kwal1 | Jul 18, 2014 | News

SurgiMab is happy to announce that it is part of the 15 laureates – selected among 87 young innovative companies – of the NETVA program. NETVA (NEw Technology Venture Accelerator) is a unique program of preparation and exposure to high-tech U.S. markets for...

8th CHIP meeting in Montpellier

by kwal1 | May 18, 2014 | News

SurgiMab will attend the 8th “CHIP / HIPEC meeting” that will take place in Montpellier on May 23rd, 2014.
« Older Entries
Next Entries »

Articles récents

  • SurgiMab Honored with the “Tech for Future 2025” Award in Healthcare by La Tribune, France – April 2, 2025
  • Françoise Cailler, CEO of surgiMab, will attend the WMIC2024 Congress in Montreal
  • SurgiMab will sponsor the next edition of the International Symposium on Fluorescence Guided Surgery, 2-3 Nov 2023 in Amsterdam
  • SurgiMab will participate to the conference “Optics in the Life Sciences” during the Optica Biophotonics Congress in Vancouver April 23 – 27, 2023
  • SurgiMab co-sponsors the Molecular-Guided Surgery meeting that will take place during the SPIE Photonics West conference in San Francisco on Jan 22-23, 2022.

Commentaires récents

No comments to show.

Contact

Francoise Cailler: +33 467 798 381
Michel Barbelanne: +33 467 798 382

Legal

Legals, privacy & cookies

  • Science
    • Technology
    • Pipeline
    • Clinical trials
    • Publications
  • About SurgiMab
    • History
    • Our team
    • Partners
  • News
  • Contact